Art

J-GLOBAL ID：201702218186758457   Reference number：17A1403559

多発性骨髄腫の最新情報:総論

Author (2)： KASAMATSU TETSUHIRO (群馬大 大学院保健学研究科) ,  MURAKAMI HIROKAZU (群馬大 大学院保健学研究科)
Material： Vita
Volume： 34  Issue： 4  Page： 40-45  Publication year： Oct. 2017 
JST Material Number： L5257A  ISSN： 0915-1028  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： human(primates) ,...
Semi thesaurus term： M protein ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1403559&from=J-GLOBAL&jstjournalNo=L5257A") }}

JST classification (2)： Blood cell tumors(=neoplasms)  (GK04000M) ,  Clinical oncology in general  (GE03010Y)

Substance index (1)： Thalidomide

Reference (9)：

• Solly S: Remarks on the pathology of mollities ossium with cases. Med-chir Tr 1844; 27: 435-461.
• Bence Jones H: On a new substance occurring in the urine of a patient with mollities ossium. Phil Trans Royal Soc (London) 1848; 1: 55-62.
• von Rustizkyon Rustizky, J. Multiples myelom. Deutsche Zeitschrift fuÈr Chirurgie 1873; 3; 162-172.
• Palumbo A, Rajkumar SV, San Miguel JF, et al: International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation. J Clin Oncol 2014; 32: 587-600.
• Greipp PR, San Miguel J, Durie BG, et al: International staging system for multiple myeloma. J Clin Oncol 2005; 23: 3412-3420.

Terms in the title (2)： 多発性骨髄腫 ,  最新情報